UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy

Journal of neurology, 2021-07, Vol.268 (7), p.2331-2338

2021

Volltextzugriff (PDF)

Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations

Frontiers in immunology, 2022-12, Vol.13, p.1070379-1070379

2022

Volltextzugriff (PDF)

A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patients

Immunobiology (1979), 2016-11, Vol.221 (11), p.1227-1236

2016

Volltextzugriff (PDF)

Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein–Barr virus infection

Immunobiology (1979), 2016-04, Vol.221 (4), p.516-527

2016

Volltextzugriff (PDF)

Current and emerging therapies for the treatment of myasthenia gravis

Neuropsychiatric disease and treatment, 2011-01, Vol.7 (1), p.151-160

2011

Volltextzugriff (PDF)

Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability

Multiple sclerosis journal - experimental, translational and clinical, 2017-04, Vol.3 (2), p.2055217317701317-2055217317701317

2017

Volltextzugriff (PDF)

Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation

Epidemiology and infection, 2021-01, Vol.149, p.e32-e32, Article e32

2021

Volltextzugriff (PDF)

A propensity score analysis for comparison of T-3b and VATET in myasthenia gravis

Neurology, 2017-07, Vol.89 (2), p.189

2017

Volltextzugriff (PDF)

Validation of the besta neurological institute rating scale for myasthenia gravis

Muscle & nerve, 2016-01, Vol.53 (1), p.32-37

2016

Volltextzugriff (PDF)

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Quality of life research, 2019-08, Vol.28 (8), p.2247-2255

2019

Volltextzugriff (PDF)

Socio-economic conditions affect health-related quality of life, during recovery from acute SARS-CoV-2 infection: Results from the VASCO study (VAriabili Socioeconomiche e COVID-19), on the “Surviving-COVID” cohort, from Bergamo (Italy)

BMC infectious diseases, 2024-08, Vol.24 (1), p.815, Article 815

2024

Volltextzugriff (PDF)

A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis

Pharmacogenetics and genomics, 2017-02, Vol.27 (2), p.51-56

2017

Volltextzugriff (PDF)

A New Thiopurine S-Methyltransferase Haplotype Associated With Intolerance to Azathioprine

Journal of clinical pharmacology, 2013-01, Vol.53 (1), p.67-74

2013

Volltextzugriff (PDF)

JAK/STAT Inhibition Normalizes Lipid Composition in 3D Human Epidermal Equivalents Challenged with Th2 Cytokines

Cells (Basel, Switzerland), 2024-05, Vol.13 (9), p.760

2024

Volltextzugriff (PDF)

Azelaic acid reduced senescence-like phenotype in photo-irradiated human dermal fibroblasts: possible implication of PPARγ

Experimental dermatology, 2013-01, Vol.22 (1), p.41-47

2013

Volltextzugriff (PDF)

Preclinical Studies of a Specific PPARγ Modulator in the Control of Skin Inflammation

Journal of investigative dermatology, 2014-04, Vol.134 (4), p.1001-1011

2014

Volltextzugriff (PDF)

P-518 INVESTIGATING RISK PERCEPTION AMONG HEALTHCARE WORKERS OF ONCOLOGICAL UNITS EXPOSED TO HANDLING ANTINEOPLASTIC DRUGS

Occupational medicine (Oxford), 2024-07, Vol.74 (Supplement_1)

2024

Volltextzugriff (PDF)

Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARγ activation

Experimental dermatology, 2010-09, Vol.19 (9), p.813-820

2010

Volltextzugriff (PDF)

Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML)

Annals of hematology, 2012-08, Vol.91 (8), p.1327-1328

2012

Volltextzugriff (PDF)

The perioperative period of liver transplantation from unconventional extended criteria donors: data from two high-volume centres

BMC anesthesiology, 2022-12, Vol.22 (1), p.390-390, Article 390

2022

Volltextzugriff (PDF)

Linking αMSH with PPARγ in B16-F10 melanoma

Pigment cell and melanoma research, 2013-01, Vol.26 (1), p.113-127

2013

Volltextzugriff (PDF)

Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study

Multiple sclerosis and related disorders, 2020-01, Vol.37, p.101461-101461, Article 101461

2020

Volltextzugriff (PDF)

Characterization of bacterial lipid profiles by using rapid sample preparation and fast comprehensive two-dimensional gas chromatography in combination with mass spectrometry

Journal of separation science, 2010-08, Vol.33 (15), p.2334-2340

2010

Volltextzugriff (PDF)

Preclinical Studies of a Specific PPAR[gamma] Modulator in the Control of Skin Inflammation

Journal of investigative dermatology, 2014-04, Vol.134 (4), p.1001

2014

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Sprache

Englisch
(32)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy

Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations

A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patients

Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein–Barr virus infection

Current and emerging therapies for the treatment of myasthenia gravis

Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability

Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation

A propensity score analysis for comparison of T-3b and VATET in myasthenia gravis

Validation of the besta neurological institute rating scale for myasthenia gravis

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Socio-economic conditions affect health-related quality of life, during recovery from acute SARS-CoV-2 infection: Results from the VASCO study (VAriabili Socioeconomiche e COVID-19), on the “Surviving-COVID” cohort, from Bergamo (Italy)

A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis

A New Thiopurine S-Methyltransferase Haplotype Associated With Intolerance to Azathioprine

JAK/STAT Inhibition Normalizes Lipid Composition in 3D Human Epidermal Equivalents Challenged with Th2 Cytokines

Azelaic acid reduced senescence-like phenotype in photo-irradiated human dermal fibroblasts: possible implication of PPARγ

Preclinical Studies of a Specific PPARγ Modulator in the Control of Skin Inflammation

P-518 INVESTIGATING RISK PERCEPTION AMONG HEALTHCARE WORKERS OF ONCOLOGICAL UNITS EXPOSED TO HANDLING ANTINEOPLASTIC DRUGS

P-366 OCCUPATIONAL EXPOSURE TO ANTINEOPLASTIC DRUGS: AN ITALIAN NETWORK OF ONCOLOGICAL HOSPITALS FOR THE BIOMONITORING OF WORKERS BY BUCCAL MICRONUCLEUS CYTOME ASSAY AND THE DETECTION OF WORKPLACE CONTAMINATION

Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARγ activation

Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML)

The perioperative period of liver transplantation from unconventional extended criteria donors: data from two high-volume centres

Linking αMSH with PPARγ in B16-F10 melanoma

Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study

Characterization of bacterial lipid profiles by using rapid sample preparation and fast comprehensive two-dimensional gas chromatography in combination with mass spectrometry

Preclinical Studies of a Specific PPAR[gamma] Modulator in the Control of Skin Inflammation

Suchergebnisse filtern